Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guobo Li

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Medicinal Chemistry|March 30, 2026
Rational Design of Broad-Spectrum Non-Nucleoside Reverse Transcriptase Inhibitors via Pharmacophore-Oriented Generative Artificial IntelligenceKun Zhang, Yuhan Lin, Ling Dong, et al.
Cancer Letters|October 11, 2014
SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivoYong Xia, Qian Lei, Yongxia Zhu, et al.
Environmental Science & Technology|June 10, 2025
Electron Withdrawal from Methane by Pt Atoms on Stannic Oxide for Highly Active Low-Temperature CombustionRan Wang, Guobo Li, Xupeng Zong, et al.
Oncotarget|January 18, 2018
A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) modelsNannan Zhang, Guo Zhang, Ning Liu, et al.
Scientific Reports|August 13, 2014
YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical modelsYong Xia, Xuejiao Song, Deliang Li, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2020
Therapeutic Effect and Mechanisms of the Novel Monosulfactam 0073Ying Sun, Xueyuan Liao, Zhigang Huang, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Medicinal Chemistry|March 30, 2026
Rational Design of Broad-Spectrum Non-Nucleoside Reverse Transcriptase Inhibitors via Pharmacophore-Oriented Generative Artificial IntelligenceKun Zhang, Yuhan Lin, Ling Dong, et al.
Cancer Letters|October 11, 2014
SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivoYong Xia, Qian Lei, Yongxia Zhu, et al.
Environmental Science & Technology|June 10, 2025
Electron Withdrawal from Methane by Pt Atoms on Stannic Oxide for Highly Active Low-Temperature CombustionRan Wang, Guobo Li, Xupeng Zong, et al.
Oncotarget|January 18, 2018
A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) modelsNannan Zhang, Guo Zhang, Ning Liu, et al.
Scientific Reports|August 13, 2014
YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical modelsYong Xia, Xuejiao Song, Deliang Li, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2020
Therapeutic Effect and Mechanisms of the Novel Monosulfactam 0073Ying Sun, Xueyuan Liao, Zhigang Huang, et al.
Pageof 5